Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - quil; aluminium hydroxide; recombinant gp70 sub-type a - parenteral liquid/solution/suspension - quil ungrouped active 10.0 ug/do; aluminium hydroxide mineral-aluminium-base active 3.0 mg/do; recombinant gp70 sub-type a vaccine-antigen/antibody active 102.0 ug/do - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | vaccine | disease caused by | equine rotavirus

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - aluminium hydroxide; quil-a; recombinant gp70 sub-type a - misc. vaccines or anti sera - aluminium hydroxide mineral-aluminium-base active 3.0 mg/do; quil-a plant active 10.0 ug/do; recombinant gp70 sub-type a vaccine-antigen/antibody active 102.0 ug/do - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - feline calicivirus - inactivated; chlamydophilia felis inactivated; feline leukaemia virus - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated; amphotericin; neomycin; polymyxin b; thiomersal - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 p; chlamydophilia felis inactivated vaccine-viral active 0.0 p; feline leukaemia virus - inactivated vaccine-viral active 0.0 p; feline panleucopenia virus - inactivated vaccine-viral active 0.0 p; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 p; amphotericin antibiotic other 0.32 ug/ml; neomycin antibiotic other 4.0 ug/ml; polymyxin b antibiotic other 14.0 iu/ml; thiomersal mercury other 18.0 ug/ml - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline leukaemia virus | feline rhinotracheitis | calicivirus (feline) | disease caused by | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - feline calicivirus - inactivated; feline leukaemia virus - inactivated; feline chlamydia psittaci - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 u; feline leukaemia virus - inactivated vaccine-viral active 0.0 u; feline chlamydia psittaci - inactivated vaccine-viral active 0.0 u; feline panleucopenia virus - inactivated vaccine-viral active 0.0 u; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 u - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline leukaemia virus | feline rhinotracheitis | calicivirus (feline) | disease caused by | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - feline leukaemia virus - inactivated - unknown - feline leukaemia virus - inactivated vaccine-viral active 0.0 - active constituent

Európai Unió - angol - EMA (European Medicines Agency)

virbac s.a. - purified p45 feline leukaemia virus envelope antigen, live feline calicivirus (strain f9), live feline viral rhinotracheitis virus (strain f2), live feline panleucopenia virus - live feline panleucopenia virus / parvovirus + live feline rhinotracheitis virus + live feline calicivirus + inactivated feline leukaemia virus - cats - for active immunisation of cats from eight weeks of age against:feline calicivirosis to reduce clinical signs.feline viral rhinotracheitis to reduce clinical signs and viral excretion.feline panleucopenia to prevent leucopenia and to reduce clinical signs.feline leukaemia to prevent persistent viraemia and clinical signs of the related disease.onset of immunity: 3 weeks after the primary vaccination for the panleucopenia and leukaemia components, and 4 weeks after the primary vaccination for the calicivirus and rhinotracheitis virus components.duration of immunity: one year after the primary vaccination for all components.

Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - feline leukemia virus gp70 surface antigen - suspension for injection - feline leukemia virus (felv) - feline leukaemia virus - cat

Írország - angol - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - inactivated sub-unit antigen (gp70) of feline leukaemia virus (felv) subtypes a,b&c (kawakami-theilen strain), quil a, cholesterol, dda (dimethyl-dioctadecyl ammonium bromide), carbopol - suspension for injection - unknown - feline leukaemia virus vaccine - feline - immunological - inactivated vaccine

Európai Unió - angol - EMA (European Medicines Agency)

zoetis belgium sa  - inactivated feline rhinotracheitis virus, inactivated feline calicivirus, inactivated feline chlamydophila felis, inactivated feline leukaemia virus, inactivated feline panleukopenia virus - immunologicals - cats - for the active immunisation of healthy cats nine weeks or older against feline panleukopenia and feline leukaemia viruses and against respiratory diseases caused by feline rhinotracheitis virus, feline calicivirus and chlamydophila felis.

Európai Unió - angol - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - feline leukaemia virus recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats of 8 weeks of age or older against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.onset of immunity has been demonstrated 2 weeks after primary vaccination course.the duration of immunity is one year after the last vaccination.